EcoDrugPlus

Adrenoceptor Alpha 2b

Ensembl ID : ENSELUG00000005695
Gene Symbol: ADRA2B
1 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSELUG00000009236
Gene Symbol: ADRA2C
1 Cross references
162 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSELUG00000014979
Gene Symbol: ADRA2C
1 Cross references
156 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSELUG00000024524
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSELUG00000017383
Gene Symbol: ADRB3A
1 Cross references
197 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSELUG00000020410
Gene Symbol: ADRB3B
1 Cross references
146 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1

Ensembl ID : ENSELUG00000015187
Gene Symbol: LOC105029080
3 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSELUG00000015104
Gene Symbol: AKR1B1.1
1 Cross references
350 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSELUG00000005981
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSELUG00000015225
Gene Symbol: LOC105029089
3 Cross references
192 Possible Orthologues:

Alpha-2b Adrenergic Receptor

Ensembl ID : ENSELUG00000008331
Gene Symbol: LOC105029447
3 Cross references
175 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSELUG00000023206
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).